ARROWHEAD PHARMACEUTICALS, INC.
ARWRPharmaceutical Preparations · SIC 2834 · CIK 0000879407
Revenue FY2025
$829.0M
Net Income
$(2.0M)
EPS (Basic)
$-0.01
Net Margin
-0.2%
ROE
-0.3%
Total Equity
$466.0M
Shares Out
141M
ARROWHEAD PHARMACEUTICALS, INC. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2003–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 8 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Platinum Investment Management
Platinum Investment Management
$5.3M
1.3%
—
Deerfield Management Company
Deerfield Management Company
$113.2M
0.6%
(11.7%)
Baker Bros. Advisors
Baker Bros. Advisors
$162.4M
0.6%
—
Holocene Advisors
Holocene Advisors
$90.2M
0.2%
NEW
Renaissance Technologies
Renaissance Technologies
$38.2M
0.0%
(54.8%)
WCM Investment Management
WCM Investment Management
$13.8M
0.0%
(0.2%)
Polen Capital Management
Polen
$0.5M
0.0%
NEW
Alps Advisors
Alps Advisors
$0.7M
0.0%
+1.6%
Insider Transactions
Reading stored insider transactions…